• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • anti-CD19 CAR T cells
    1 Drug classified under this active ingredient

    All the Active Ingredient Drugs

    not in the basket chart

    Advanced Therapy. anti-CD19 CAR T cells 0.4 – 2 × 10^8 cells.
    0.4 – 2 × 108 cells dispersion for IV. Autolog. use only. Single dose 2 × 106 /kg b.w. in approx. 68 mL dispers. in an infus. bag. Recommen. to be infus. 3 to 14 days. Aft. complet.  lymphodeplet. chemother. See lit.
    Tmt. adult pts. with relapse. or refract. mantle cell lymphoma after 2 or more lines of sys. ther. incl. Bruton's tyrosine kinase (BTK) inhib. unless inelig. to BTK inhib. Not indicat. for tmt. pts. with active CNS lymphoma.
    C/I: hypresens. see lit.